STOCK TITAN

Rhythm Pharmaceuticals (RYTM) Free Cash Flow by Year

RYTM NASDAQ

Rhythm Pharmaceuticals, Inc. recorded an outflow of $116.6M in free cash flow in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Rhythm Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Free Cash Flow -$116.6M
YoY n/m
5Y CAGR n/m
10Y CAGR n/m
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RYTM Free Cash Flow by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
Free Cash Flow-$116.6Mn/m-$113.9Mn/m-$136.2Mn/m-$173.7Mn/m-$146.4Mn/m-$122.2Mn/m-$126.1Mn/m-$62.8Mn/m-$29.6Mn/m-$24.3Mn/m-$6.8M

RYTM Free Cash Flow by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Free Cash FlowN/AN/AN/A-$26.3MN/AN/AN/AN/AN/AN/AN/AN/A

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Rhythm Pharmaceuticals, Inc. financials

Frequently Asked Questions

Rhythm Pharmaceuticals, Inc. recorded an outflow of $116.6M in free cash flow in fiscal year 2025.

Rhythm Pharmaceuticals, Inc. (RYTM) reported an outflow of $113.9M in free cash flow in fiscal year 2024 and an outflow of $116.6M in free cash flow in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

Across the 11 fiscal years this page covers, Rhythm Pharmaceuticals, Inc. (RYTM) free cash flow went from -$6.8M in fiscal year 2015 to -$116.6M in fiscal year 2025.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Rhythm Pharmaceuticals, Inc. (RYTM) reported on that line in every period on record.